IP vs MRNA · P/E 43, $26.62B cap vs rev $1.94B
International Paper (IP) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
IP does not have a complete income-statement cache yet.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the IP and MRNA stock pages for the full models.
Not investment advice.